-Youngro Byun Researcher Activity Profile

Research Author Detailed Information 

Youngro Byun Publication Rate By Year

Youngro Byun has published 2 paper(s) in 2002, 2 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 1 paper(s) in 2006, 6 paper(s) in 2007, 2 paper(s) in 2008, for a total of 15 research publications in total.

Youngro Y Byun Author Information

LAST NAME: byun

FIRST NAME: youngro

INITIALS: Y

AFFILIATION:

Papers

Youngro Byun's Publication Record

1. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation. Year Published: 2006
Center for Cell and Macromolecular Therapy, Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, 1 Oryong-dong, Buk-gu, Gwangju 500-712, Korea.
2. Liphophilic complexation of heparin based on bile acid for oral delivery. Year Published: 2007
College of Pharmacy, Seoul National University, Seoul 151-742, South Korea.
3. Glucosylated heparin derivatives as non-toxic anti-cancer drugs. Year Published: 2007
Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, 1 Oryong-dong, Buk-gu, Gwangju 500-712, South Korea.
4. MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin. Year Published: 2007
Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
5. Toxicity screening after repeated dose of a newly developed oral heparin derivative in male cynomolgus monkeys. Year Published: 2007
6. Toxicity screening after repeated dose of a newly developed oral heparin derivative in male cynomolgus monkeys. Year Published: 2007
7. MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin. Year Published: 2007
Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
8. Combination Therapy of Heparin-Deoxycholic Acid Conjugate and Doxorubicin against Squamous Cell Carcinoma and B16F10 Melanoma. Year Published: 2008
Biomedical Research Center, Korea Institute of Science and Technology, 39-1 Hawolgok-dong, Seongbuk-gu, Seoul, 136-791, South Korea.
9. In vivo biocompatibility studies of poly(D,L-lactide)/poly(ethylene glycol)-poly(L-lactide) microspheres containing all-trans-retinoic acid. Year Published: 2002
Department of Materials Science and Engineering, Kwangju Institute of Science and Technology, Gwangju, Korea.
10. Improved blood compatibility by sustained release of heparin-deoxycholic acid conjugates in a PCL-PEG multiblock copolymer matrix. Year Published: 2002
Department of Materials Science and Engineering, Kwangju Institute of Science and Technology, Gwangju, Korea.
11. Synthesis and characterization of poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) biodegradable micelles. Year Published: 2003
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Taejon 305-701, South Korea.
12. Preparation of a stable phospholipid monolayer grafted onto a methacryloyl-terminated substrate as blood compatible materials. Year Published: 2003
Center for Biomaterials and Biotechnology, Department of Materials Science and Engineering, Kwangju Institute of Science and Technology, 1 Oryong-dong Puk-gu, Gwangju 500-712, South Korea.
13. Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks. Year Published: 2004
Department of Materials Science and Engineering, Kwangju Institute of Science and Technology, 1 Oryong-dong, Buk-gu, Gwangju 500-712, South Korea.
14. Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. Year Published: 2005
Center for Biomaterials and Biotechnology, Department of Materials Science and Engineering, Gwangju Institute of Science and Technology, 1 Oryong-dong, Puk-gu, Gwangju 500-712, South Korea.
15. Combination therapy of heparin-deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanoma. Year Published: 2008
Biomedical Research Center, Korea Institute of Science and Technology, 39-1 Hawolgok-dong, Seongbuk-gu, Seoul, 136-791, South Korea.